AIP
HGEN

Ameritas Investment Partners’s HUMANIGEN, INC. HGEN Stock Holding History

Ameritas Investment Partners’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-3,517
Closed -$11K – 3320
2022
Q1 		$11K Hold
3,517
– – ﹤0.01% 2783
2021
Q4 		$13K Hold
3,517
– – ﹤0.01% 2831
2021
Q3 		$21K Hold
3,517
– – ﹤0.01% 2684
2021
Q2 		$61K Buy
+3,517
New +$64.1K ﹤0.01% 2063

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameritas Investment Partners's HGEN Position: Q2 2022 in Review

Ameritas Investment Partners sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 3,517 shares — an estimated $11K sold.

Ameritas Investment Partners first reported a position in HGEN in Q2 2021 and held it in 4 quarters. The position peaked at $61K in Q2 2021. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • Ameritas Investment Partners reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,517 HUMANIGEN, INC. shares in Q2 2022, an estimated $11K.
  • Ameritas Investment Partners first reported a position in HUMANIGEN, INC. in Q2 2021 and held it in 4 quarters.
  • Ameritas Investment Partners's HUMANIGEN, INC. position peaked at $61K in Q2 2021.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.